Speech-Language Pathologists in Mount Angel, OR Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Michelle Flynn, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 540 S Main St, Mount Angel, OR 97362 Phone: 503-845-6841 Fax: 503-845-9229 |
Merissa Zielinski Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 540 S Main St, Mount Angel, OR 97362 Phone: 503-845-2736 Fax: 503-845-9229 |
News Archive
New URMC trial to evaluate carvedilol for high blood pressure
Researchers at the University of Rochester Medical Center are testing whether different doses of an established blood pressure medication can provide the same benefits as a standard dose in people with mild hypertension, possibly with fewer side effects and at a lower cost. The newly launched clinical trial, funded with a $1.9 million grant from the National Heart Lung and Blood Institute, is the first of its kind in the United States.
Researchers find link between resilience to dyslexia and gray matter in the brain
Dyslexia, a reading disorder, is characterized by a difficulty in "decoding" - navigating between the visual form and sounds of a written language.
State roundup: Calif. HMO report cards, Ore. family planning bills challenged, Texas managed care
Gov. Corbett's new budget proposal would cost the city $42 million in mostly mental health and addiction treatment funding, but city officials say the impact will be worsened by ensuing needs for emergency shelter, child welfare, and other services. … The city Health Department faces an additional $7 million in state cuts. That would reduce the number of beds in the city nursing home and cost hospice beds for AIDS victims, officials said.
3D test for diagnosing malignant melanoma
UK scientists have developed a 3D test for malignant melanoma that can identify problems not easily spotted in a standard two-dimensional view of the pattern on the skin. The researchers describe the technique in detail in the latest issue of the International Journal of Modelling, Identification and Control.
Immunotherapy shows promise in treatment of Type 1 diabetes
Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body's own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.
› Verified 4 days ago
Occupational Therapists
Physical Therapists
Speech-Language Pathologists